Technology
WELL Health Reports Record Results for Q2-2024 Driven by an Acceleration in Organic Growth and Raises Annual Guidance
Published
4 months agoon
By
WELL achieved record quarterly revenues of $243.1 million in Q2-2024, an increase of 42% as compared to Q2-2023 driven by acquisitions and overall organic growth(3) of 21%.WELL achieved record Adjusted EBITDA(1) of $30.9 million in Q2-2024, an increase of 11% as compared to Q2-2023.WELL achieved a record total of 1.4 million patient visits in Q2-2024 an increase of 38% compared to Q2-2023 and representing 5.6 million patient visits on an annualized run-rate basis.WELL’s US digital revenues attributable to Circle Medical and Wisp grew organically by 40% to $56.3M in Q2 and achieved $3.5 million in Adjusted EBITDA an improvement of $5.3 million realizing investments made in the previous year.WELL is raising its guidance range for 2024 annual revenue to be between $970 million to $990 million and maintaining Adjusted EBITDA guidance to be in the upper range of $125 million to $130 million, despite higher costs due to our projection of significantly lower share issuances and stock-based incentives. WELL also maintains guidance for Free cashflow available to shareholders to be approximately $55 million.
VANCOUVER, BC, Aug. 14, 2024 /CNW/ – WELL Health Technologies Corp. (TSX: WELL, OTCQX: WHTCF) (the “Company” or “WELL”), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce its interim consolidated financial results for the quarter ended June 30, 2024.
Hamed Shahbazi, Founder and CEO of WELL, commented, “The second quarter of 2024 exceeded expectations, showcasing the strength of our technology-driven care platforms. We are very pleased to report 42% year-over-year revenue growth, driven by accelerated organic growth of 21% which includes contribution from our absorption program where we recruit clinics to our network for nominal cost. This marks our 22nd consecutive record-breaking revenue quarter, highlighting our sustained momentum. We are proud to once again improve our annual revenue guidance to $970 million to $990 million and report that we are on track to achieve one billion in revenues by the end of 2024 if we include acquisitions that are currently in our acquisition pipeline. Additionally, we are maintaining our guidance on Adjusted EBITDA in the upper range of $125 million to $130 million despite facing additional costs as a result of our projection of materially reduced share issuances for stock-based compensation. We remain focused on enhancing profitability and capital efficiency and continue to project a 30% year-over-year increase in free cash flow to shareholders in 2024. Our strong organic growth and healthy cash flows increasingly allow us to fund acquisitions, earn-outs, and employee incentives with cash. We are still on track to deliver record revenue, Adjusted EBITDA, and Net Income in 2024, while increasing cash flows, reducing debt, improving leverage, lowering share issuances, and decreasing earn-out payments.”
Mr. Shahbazi further added, “As of the end of Q2-2024, WELL proudly supported a network of over 3,900 providers and clinicians delivering care through our physical and virtual clinics. Our Canadian clinic transformation program continues to drive efficiencies in our clinics systemwide while driving enhanced organic growth. The clinics that have recently joined our network under our M&A or absorption programs are improving in terms of their overall operations and profitability. This success is driven by our focus on cost optimization, digital workflow integration, patient engagement technologies, and the implementation of advanced AI tools such as the ambient AI scribe and various co-pilot technologies powered by our partner HEALWELL AI. We remain committed to empowering healthcare professionals with the latest in cutting-edge technology.”
Eva Fong, WELL’s Chief Financial Officer, added, “I am proud to announce that during Q2 2024 we paid down $14 million in debt and reduced our leverage ratio to 2.67x for bank debt and 3.45x for all debt including convertible debentures. I’m also pleased to report that we achieved positive IFRS net income in Q2 2024, and notably, our net income remains positive even if we exclude the unrealized gains from our investments in HEALWELL AI. Much of our progress is due to the comprehensive cost-cutting program that was implemented earlier this year that has significantly strengthened our operational efficiency and generated substantial annualized cost savings. In Q2-2024, we generated a record $35.2 million in cash flow from operating activities. In addition to these substantial savings and strong cash flows, this fiscal year we plan to reduce our yearly share dilution to its lowest level ever since being launched as a company. The Company is in an excellent position to continue funding its organic growth and future acquisition plans through cash flows from operations.”
Second Quarter 2024 Financial Highlights:
WELL achieved record quarterly revenue of $243.1 million in Q2-2024, an increase of 42% as compared to revenue of $170.9 million generated in Q2-2023. This growth was mainly driven by organic growth of 21% including clinic absorptions and 16% without absorptions.Adjusted Gross Profit(1) was $107.4 million in Q2-2024, an increase of 18% as compared to Adjusted Gross Profit(1) of $90.8 million in Q2-2023.Adjusted Gross Margin(1) percentage was 44.2% during Q2-2024 compared to Adjusted Gross Margin(1) percentage of 53.1% in Q2-2023. The decline in Adjusted Gross Margin percentage is mainly attributed to the acquisition of businesses in the past year that had lower gross margin percentage.Adjusted EBITDA(1) was $30.9 million in Q2-2024, an increase of 11% as compared to Adjusted EBITDA(1) of $27.8 million in Q2-2023.Adjusted EBITDA to WELL shareholders was $23.0 million in Q2-2024, an increase of 3% as compared to Adjusted EBITDA to WELL shareholders of $22.3 million in Q2-2023.Adjusted Net Income(1) was $12.3 million, or $0.05 per share in Q2-2024, as compared to Adjusted Net Income(1) of $14.4 million, or $0.06 per share in Q2-2023.Net Income was $117.0 million or $0.45 per share in Q2-2024, driven by material unrealized gains of WELL’s investment in HEALWELL AI.Free cashflow attributable to WELL shareholders(1) was $8.7 million during Q2-2024, compared to $9.4 million during Q2-2023.
Second Quarter 2024 Segmented Results
Canadian Patient Services revenue was $76.7 million in Q2-2024, an increase of 42% as compared to $54.2 million in Q2-2023.SaaS and Technology Services revenue was $16.9 million in Q2-2024, an increase of 27% as compared to $13.3 million in Q2-2023.U.S. Patient and Provider Services revenue was $149.5 million in Q2-2024, an increase of 45% as compared to $103.5 million in Q2-2023.Canadian Patient Services Adjusted EBITDA was $9.0 million in Q2-2024, an increase of 2% as compared to $8.9 million in Q2-2023 mainly due to lapping of a number of one-time positive impacts to profitability in Q2-2023.SaaS and Technology Services Adjusted EBITDA was $4.0 million in Q2-2024, an increase of 94% as compared to $2.1 million in Q2-2023.U.S. Patient and Provider Services Adjusted EBITDA was $23.2 million in Q2-2024, an increase of 9% as compared to $21.3 million in Q2-2023.
Second Quarter 2024 Patient Visit Metrics:
WELL achieved a record 1.4 million patient visits in Q2-2024, an increase of 38% compared to Q2-2023 and representing 5.6 million patient visits on an annualized run-rate basis. Patient visits were comprised of 759,000 patient visits in Canada and 640,000 patient visits in the US. Canadian Patient Services visits increased 41% while US Patient Services visits increased 34%, on a year-over-year basis. Growth in patient visits over the past year was primary driven by organic growth, including the clinic absorption program as well as acquisitions.
Total care interactions were 2.1 million in Q2-2024, a year-over-year increase of 48% compared to Q2-2023 and representing 8.4 million total care interactions on an annualized run-rate basis.
Q2-24
Q1-24
Q2-23
Q/Q
Growth
Y/Y
Growth
Y/Y Organic
Growth
Canada Patient Visits
759,000
733,000
537,000
4 %
41 %
21 %
US Patient Visits
640,000
577,000
478,000
11 %
34 %
31 %
Total Visits
1,399,000
1,310,000
1,015,000
7 %
38 %
26 %
Technology Interactions
622,000
599,000
411,000
4 %
51 %
51 %
Billed Provider Hours
83,000
89,000
0
-7 %
N/A
N/A
Total Care Interactions(2)
2,104,000
1,998,000
1,426,000
5 %
48 %
48 %
Second Quarter 2024 Business Highlights:
On April 30, 2024, the Company announced a five-year collaboration with Microsoft to enhance digital healthcare across North America, integrating Microsoft’s cloud and AI with WELL’s platform. This partnership focuses on elevating WELL’s scalability and operational efficiency, aiming to transform healthcare delivery for large enterprises, including the public sector. The collaboration will also modernize WELL’s cloud infrastructure, optimize costs, ensure data security, and integrate Azure OpenAI Service to advance healthcare solutions.
On May 2, 2024, the Company announced the launch of the second generation WELL AI Decision Support (“WAIDS”), featuring advanced chronic disease screening for conditions like diabetes and hypertension. This enhanced WAIDS version facilitates patient risk stratification and expands its disease detection capabilities. Powered by HEALWELL AI, the technology aids clinicians in decision-making, addressing chronic diseases that significantly impact Canadians.
On June 1, 2024, the Company completed the purchase to acquire all primary care medical clinics operated by Shoppers Drug Mart Inc. (“Shoppers”) under “The Health Clinic by Shoppers™” brand. The acquisition included 10 clinics, with over 35 physicians, located in British Columbia and Ontario.
Events Subsequent to June 30, 2024:
On July 10, 2024, the Company announced the approval of a historic $44 million project, Health Compass II, the largest DIGITAL project ever awarded to advance AI-powered tech enablement for care providers. This initiative, led by WELL and its consortium partners, aims to enhance AI and interoperability in Canadian healthcare. As the lead commercialization partner and first customer, WELL will provide expertise and interoperability, enabling the development of new AI tools to support healthcare providers and improve patient outcomes.
On July 17, 2024, the Company announced the launch of its AI-powered co-pilot for cardiologists, powered by HEALWELL AI, to improve the detection of cardiovascular disease (CVD). This co-pilot, an extension of the WELL AI Decision Support (WAIDS) product offering, will be deployed in WELL Diagnostic Centers, Canada’s largest cardiology and medical diagnostic group, across over 40 locations in Ontario. This initiative aims to assist cardiologists in identifying high-risk patients, enhancing early detection and management of CVD.
Outlook:
WELL anticipates maintaining its strong performance through the remainder of 2024, with a strategic focus on enhancing operations for organic growth and profitability. The Company aims to pursue capital-efficient growth opportunities while effectively managing costs to deliver robust growth and sustained cash flow to shareholders. The Company’s strong organic growth and healthy cash flow position it well to continue executing its growth strategies while progressively reducing debt.
Management is pleased to improve its guidance, which includes only announced acquisitions, as follows:
Annual revenue for 2024 is projected to be in the range of $970 million to $990 million.Adjusted EBITDA for 2024 is projected to be in the upper range of $125 million to $130 million, despite increased cash costs due to lower share issuance and share based incentives.Free cashflow attributable to WELL shareholders is expected to be approximately $55 million.
WELL plans to advance its U.S. and Canadian Patient Services businesses through both organic and strategic growth, prioritizing capital efficiency. This approach will enable the Company to use business cash flows for debt reduction and minimizing share issuance. In Canada, WELL aims to strengthen its market leadership as the nation’s premier pan-Canadian clinical network, offering a highly integrated, tech-enabled outpatient healthcare system.
Leveraging its deep technological expertise, WELL is prioritizing investments in AI technologies, with plans to continue to develop and launch innovative products and enhancements across its provider and clinic network.
Conference Call:
WELL will hold a conference call to discuss its 2024 Second Quarter financial results on Wednesday, August 14, 2024, at 1:00 pm ET (10:00 am PT). Please use the following dial-in numbers: 416-764-8650 (Toronto local), 778-383-7413 (Vancouver local), 1-888-664-6383 (Toll-Free) or +1-416-764-8650 (International).
The conference call will also be simultaneously webcast and can be accessed at the following audience URL: https://well.company/events.
Selected Unaudited Financial Highlights:
Please see SEDAR for complete copies of the Company’s condensed interim consolidated financial statements and interim MD&A for the quarter ended June 30, 2024.
Quarter ended
Six months ended
June 30,
2024
March 31,
2024
June 30,
2023
June 30,
2024
June 30,
2023
$’000
$’000
$’000
$’000
$’000
Revenue
243,147
231,562
170,922
474,709
340,347
Cost of sales (excluding depreciation and amortization)
(135,766)
(129,342)
(80,099)
(265,108)
(163,355)
Adjusted Gross Profit(1)
107,381
102,220
90,823
209,601
176,992
Adjusted Gross Margin(1)
44.2 %
44.1 %
53.1 %
44.2 %
52.0 %
Adjusted EBITDA(1)
30,880
28,314
27,789
59,194
54,472
Net income (loss)
116,976
19,600
(2,016)
136,576
(12,643)
Adjusted Net Income (1)
12,284
20,239
14,361
32,523
28,486
Earnings (loss) per share, basic (in $)
0.45
0.06
(0.03)
0.52
(0.09)
Earnings (loss) per share, diluted (in $)
0.43
0.06
(0.03)
0.48
(0.09)
Adjusted Net Income per share, basic and diluted (in $) (1)
0.05
0.08
0.06
0.13
0.12
Reconciliation of net income (loss) to Adjusted EBITDA:
Net income (loss) for the period
116,976
19,600
(2,016)
136,576
(12,643)
Depreciation and amortization
17,307
16,560
14,041
33,867
28,563
Income tax expense (recovery)
(1,959)
(178)
1,889
(2,137)
2,081
Interest income
(279)
(238)
(127)
(517)
(315)
Interest expense
9,689
9,541
7,828
19,230
15,602
Rent expense on finance leases
(4,129)
(4,114)
(2,581)
(8,243)
(5,071)
Stock-based compensation
4,765
5,477
6,134
10,242
12,733
Foreign exchange gain
(72)
(32)
(65)
(104)
(349)
Time-based earnout expense
15
2,112
1,476
2,127
12,330
Change in fair value of investments
(116,327)
(13,957)
–
(130,284)
–
Gain on disposal of assets and investments
–
(11,284)
(1,517)
(11,284)
(1,517)
Share of net (income) loss of associates
(177)
1,064
91
887
188
Other items
753
–
1,798
753
1,798
Transaction, restructuring and integration costs expensed
4,318
3,763
838
8,081
1,072
Adjusted EBITDA(1)
30,880
28,314
27,789
59,194
54,472
Attributable to WELL shareholders
23,019
21,371
22,287
44,390
42,919
Attributable to Non-controlling interests
7,861
6,943
5,502
14,804
11,553
Adjusted EBITDA(1)
WELL Corporate
(5,320)
(4,767)
(4,456)
(10,087)
(8,981)
Canada and others
13,032
14,474
10,942
27,506
22,747
US operations
23,168
18,607
21,303
41,775
40,706
Adjusted EBITDA(1) attributable to WELL shareholders
WELL Corporate
(5,320)
(4,767)
(4,456)
(10,087)
(8,981)
Canada and others
12,645
14,247
10,798
26,892
22,308
US operations
15,694
11,891
15,945
27,585
29,592
Adjusted EBITDA(1) attributable to Non-controlling interests
Canada and others
387
227
144
614
439
US operations
7,474
6,716
5,358
14,190
11,114
Reconciliation of net income (loss) to Adjusted Net income:
Net income (loss) for the period
116,976
19,600
(2,016)
136,576
(12,643)
Amortization of acquired intangible assets
11,361
11,520
10,720
22,881
21,750
Time-based earnout expense
15
2,112
1,476
2,127
12,330
Stock-based compensation
4,765
5,477
6,134
10,242
12,733
Change in fair value of investments
(116,327)
(13,957)
–
(130,284)
–
Other items
753
–
1,798
753
1,798
Non-controlling interest included in net income (loss)
(5,259)
(4,513)
(3,751)
(9,772)
(7,482)
Adjusted Net Income (1)
12,284
20,239
14,361
32,523
28,486
Footnotes:
Non-GAAP financial measures and ratios.
In addition to results reported in accordance with IFRS, the Company uses certain non-GAAP financial measures as supplemental indicators of its financial and operating performance. These non-GAAP financial measures include Adjusted Net Income, Adjusted Net Income Per Share, Adjusted EBITDA, Adjusted Gross Profit, Adjusted Gross Margin, and Adjusted Free Cash Flow. The Company believes these supplementary financial measures reflect the Company’s ongoing business in a manner that allows for meaningful period-to-period comparisons and analysis of trends in its business.
Adjusted Net Income and Adjusted Net Income per Share The Company defines Adjusted Net Income as net income (loss), after excluding the effects of stock-based compensation expense, amortization of acquired intangible assets, time-based earnout expense, change in fair value of investments, non-controlling interests, and revenue precluded from recognition under IFRS 15 that relates to certain patient services revenue that the Company believes should be recognized as revenue based on its contractual relationships. Adjusted Net Income Per Share is Adjusted Net Income divided by weighted average number of shares outstanding. The Company believes that these non-GAAP financial measures provide useful information to analyze our results, enhance a reader’s understanding of past financial performance and allow for greater understanding with respect to key metrics used by management in decision making. More specifically, the Company believes Adjusted Net Income is a financial metric that tracks the earning power of the business that is available to WELL shareholders.
EBITDA and Adjusted EBITDA EBITDA and Adjusted EBITDA are non-GAAP measures. EBITDA represents net income (loss) before interest, taxes, depreciation, and amortization. The Company defines Adjusted EBITDA as EBITDA (i) less net rent expense on premise leases considered to be finance leases under IFRS and (ii) before transaction, restructuring, and integration costs, time-based earn-out expense, change in fair value of investments, share of loss of associates, foreign exchange gain/loss, and stock-based compensation expense, (iii) revenue precluded from recognition under IFRS 15 that relates to certain patient services revenue that the Company believes should be recognized as revenue based on its contractual relationships, and (iv) gains/losses that are not reflective of ongoing operating performance. The Company considers Adjusted EBITDA a financial metric that measures cash that the Company can use to fund working capital requirements, service future interest and principal debt repayments and fund future growth initiatives. EBITDA and Adjusted EBITDA should not be considered alternatives to net income (loss), cash flow from operating activities or other measures of financial performance in accordance with IFRS.
Adjusted Gross Profit and Adjusted Gross Margin The Company defines Adjusted Gross Profit as revenue less cost of sales (excluding depreciation and amortization) and Adjusted Gross Margin as adjusted gross profit as a percentage of revenue. Adjusted gross profit and adjusted gross margin should not be construed as an alternative for revenue or net income (loss) determined in accordance with IFRS. The Company does not present gross profit in its consolidated financial statements as it is a non-GAAP financial measure. The Company believes that adjusted gross profit and adjusted gross margin are meaningful metrics that are often used by readers to measure the Company’s efficiency of selling its products and services.
Adjusted Free Cashflow The Company defines Adjusted Free Cashflow as Adjusted EBITDA Attributable to Shareholders, less cash interest, less cash taxes and less capital expenditures. Adjusted Net income, Adjusted Net Income per Share, Adjusted EBITDA, Adjusted Gross Profit, Adjusted Gross Margin, and Adjusted Free Cashflow are not recognized measures for financial statement presentation under IFRS and do not have standardized meanings. As such, these measures may not be comparable to similar measures presented by other companies and should be considered as supplements to, and not as substitutes for, or superior to, the corresponding measures calculated in accordance with IFRS. Total Care Interactions are defined as Total Visits plus Technology Interactions plus Billed Provider Hours.Organic growth includes growth attributable to “absorptions” which are characterized by clinics acquired for nominal consideration (ie. Less than 0.02x revenues). The overall organic growth inclusive of absorptions in Q2 was 21% but would have been 16.% without absorptions.
WELL HEALTH TECHNOLOGIES CORP.
Per: “Hamed Shahbazi”
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL Health Technologies Corp.
WELL’s mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL’s comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL’s solutions enable more than 37,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 180 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL’s solutions are focused on specialized markets such as the gastrointestinal market, women’s health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol “WELL” and on the OTC Exchange under the symbol “WHTCF”. To learn more about WELL, please visit: www.well.company.
Forward-Looking Statements
This news release may contain “Forward-Looking Information” within the meaning of applicable Canadian securities laws, including, without limitation: information regarding the Company’s goals, strategies and growth plans; annual revenue and patient-visit run rates; free cash-flow guidance; expectations regarding continued revenue and EBITDA growth; expectations surrounding the reduction in debt, share issuances and earn-out payments; expected annual savings from various cost cutting initiatives; the expected benefits and synergies of completed acquisitions ; and the expected financial performance as well as information in the “Outlook” section herein. Forward-Looking Information are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive uncertainties, and contingencies. Forward-Looking Information generally can be identified by the use of forward-looking words such as “may”, “should”, “will”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-Looking Information involve known and unknown risks, uncertainties and other factors that may cause future results, performance, or achievements to be materially different from the estimated future results, performance or achievements expressed or implied by the Forward-Looking Information and the Forward-Looking Information are not guarantees of future performance. WELL’s comments expressed or implied by such Forward-Looking Information are subject to a number of risks, uncertainties, and conditions, many of which are outside of WELL ‘s control, and undue reliance should not be placed on such information. Forward-Looking Information are qualified in their entirety by inherent risks and uncertainties, including: direct and indirect material adverse effects from adverse market conditions; risks inherent in the primary healthcare sector in general; regulatory and legislative changes; that future results may vary from historical results; inability to obtain any requisite future financing on suitable terms; the expected profitability of acquisition targets; the expected benefits from different commercial partnerships; any inability to realize the expected benefits and synergies of acquisitions; that market competition may affect the business, results and financial condition of WELL and other risk factors identified in documents filed by WELL under its profile at www.sedar.com, including its most recent Annual Information Form. Except as required by securities law, WELL does not assume any obligation to update or revise any forward-looking information, whether as a result of new information, events or otherwise.
This news release contains future-oriented financial information and financial outlook information (collectively, “FOFI”) about estimated annual run-rate revenue and Adjusted EBIDTA, all of which are subject to the same assumptions, risk factors, limitations, and qualifications as set out in the above paragraph. The actual financial results of WELL may vary from the amounts set out herein and such variation may be material. WELL and its management believe that the FOFI has been prepared on a reasonable basis, reflecting management’s best estimates and judgments. However, because this information is subjective and subject to numerous risks, it should not be relied on as necessarily indicative of future results. Except as required by applicable securities laws, WELL undertakes no obligation to update such FOFI. FOFI contained in this news release was made as of the date hereof and was provided for the purpose of providing further information about WELL’s anticipated future business operations on an annual basis. Readers are cautioned that the FOFI contained in this news release should not be used for purposes other than for which it is disclosed herein.
Neither the TSX nor its Regulation Services Provider (as that term is defined in policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.
View original content to download multimedia:https://www.prnewswire.com/news-releases/well-health-reports-record-results-for-q2-2024-driven-by-an-acceleration-in-organic-growth-and-raises-annual-guidance-302222234.html
SOURCE WELL Health Technologies Corp.
You may like
Technology
TESSAN Teams Up with One Tree Planted to Launch Global Tree Planting Initiative
Published
51 minutes agoon
December 24, 2024By
SHELBURNE, Vt., Dec. 24, 2024 /PRNewswire/ — The leading charging solution provider TESSAN has announced a new initiative to plant 10,000 trees across the United States and beyond. Through its collaboration with One Tree Planted, a non-profit organization dedicated to global reforestation, TESSAN showcases its long-term commitment to environmental sustainability and climate action as a climate-friendly brand.
Alex, the CEO of TESSAN, emphasized the brand’s dedication to fostering meaningful connections, not only between people and places but also between humanity and the planet. “We are excited to join One Tree Planted to make contribution to global reforestation,” said Alex. “Our journey at TESSAN is not just about creating innovative charging solutions. It is about establishing meaningful connections, and planting trees is one of the most direct actions to forge this bond. Through our collaboration with One Tree Planted, we aim to strengthen our connection with the Earth and encourage travelers using our products to seize every opportunity to engage in climate action, truly exploring the world and building a green connection with the planet.”
One Tree Planted is committed to global tree planting and forest restoration efforts. The organization operates with a mission to engage transparently and effectively in worldwide forest conservation by planting one tree for every dollar donated. Their initiatives span the globe, striving to enhance ecosystem sustainability.
The shared vision between TESSAN and One Tree Planted has brought their collaboration to reality. TESSAN consistently prioritizes its responsibility to protect and maintain resources for future generations. In August, TESSAN received ClimatePartner certification, elevating its dedication to sustainability by assessing the carbon footprint of its products, setting targets for emission reduction, and persistently striving to meet these objectives.
Even before this certification, TESSAN has been dedicated to reducing carbon emissions by integrating sustainability principles throughout its product lifecycle. The company promotes a low-carbon lifestyle, encouraging eco-friendly practices in product development and employee habits.
Moreover, in partnership with ClimatePartner, TESSAN has backed a biogas initiative in Nepal, effectively neutralizing 386 tons of CO2 equivalent. This project transforms cow manure combined with water into biogas via anaerobic digestion, substituting firewood for cooking and aiding in the reduction of deforestation.
TESSAN has long championed climate action within the travel charging industry. Its sustainability efforts encompass eco-friendly product designs crafted from recycled and biodegradable materials, green manufacturing processes that prioritize energy efficiency and waste reduction, and sustainable packaging made from environmentally friendly materials. The company also emphasizes transparency in its supply chain to encourage responsible sourcing practices.
TESSAN’s brand philosophy, “The Journey Begins at Home,” underscores the importance of protecting and preserving the planet as it is everyone’s home. Through compact product designs, minimalist packaging, and the use of renewable materials, TESSAN is dedicated to promoting the belief in “Charging for a Greener Future” to travelers around the globe. With a global user base exceeding 20 million, the brand’s vision of a climate-friendly journey continues to gain widespread acceptance.
About TESSAN
TESSAN, a trusted partner in charging solutions, is committed to enriching experiences both at home and during travel. The brand offers a wide array of products, including multifunctional power strips, travel adapters, wall extenders, and smart home devices. Supported by a robust R&D and production team, TESSAN develops innovative socket products for users across the globe. With the trust of over 20 million users, TESSAN empowers their journeys from home to every destination, promoting environmentally conscious electricity usage.
For more information, visit www.tessan.com or the TESSAN Amazon store, and follow TESSAN on Facebook, Instagram, and YouTube.
View original content to download multimedia:https://www.prnewswire.com/news-releases/tessan-teams-up-with-one-tree-planted-to-launch-global-tree-planting-initiative-302338830.html
SOURCE TESSAN
Technology
Passive Bitcoin Income: The Best Cloud Mining Platforms for Reliable Earnings
Published
2 hours agoon
December 24, 2024By
A guide to short-term Bitcoin mining, featuring BitFuFu, ZT Mining, and Hashing24 for flexible contracts and quick profits.
READING, England, Dec. 24, 2024 /PRNewswire-PRWeb/ — Engaging in bitcoin mining presents an accessible and potentially lucrative venture for those intrigued by digital currencies but reluctant to endure the complexities and long timelines associated with traditional investment routes.
Short-term mining contracts are popular among beginners as they look to improve their understanding of the market. These contracts range from as brief as a day to several months, offering immediate entry into the mining scene without the long-term entanglements.
The appeal of short-term bitcoin mining is magnified by the ease of access to these services. Legit cloud mining platforms give individuals the opportunity to lease mining power remotely and eliminate traditional obstacles such as acquiring and maintaining hardware. Investors simply select a mining plan that aligns with their financial objectives and risk tolerance, and the platform handles the operational complexities
BitFuFu Cloud Mining
BitFuFu offers a diverse range of contracts, from short to medium-term, tailored to different risk appetites and investment levels. For those looking for quick, low-risk ventures, the Easy Mining plans range from 3 to 50 days, with a starting investment as low as . These plans are ideal for newcomers wanting to dip their toes in mining without significant upfront costs. For example, the Easy Mining 3 Days plan, with an estimated acquisition cost of 5,602.2, starts investments at , promising a low-risk and low-return profile.
On the other hand, BitFuFu’s Pro Mining contracts target more seasoned miners looking for higher returns, albeit with higher risks. The Pro Mining S19 XP 30 Days plan, for instance, boasts a 107.48% return, indicative of the lucrative possibilities for those willing to invest more heavily in their mining endeavors.
ZT Mining
ZT Mining lets you mine over ten different cryptocurrencies like Bitcoin, Dogecoin, Monero, and Zcash. This means you can pick and choose and not just stick to one kind, making it fun to try out different ones. They also make sure everything is super safe. They use special security to protect your information and have strong defenses against online attacks, so everything runs smoothly without any interruptions.
ZT Mining is really cool because it has lots of different mining contracts that can last just a day or even longer, so you can see how much money you can make in a short time or a bit longer. They have a special starter package for only $35, and it’s just for one day. If you try this, you’ll get $36 back the next day, which means you make a $1 profit.
That’s pretty awesome for just a day’s work, right? Plus, if you feel like going bigger, they have longer plans where you can earn a lot more money, like the 15-day plan for mining Dogecoin that can make you thousands in profit!
Hashing24
Hashing24 makes it easy to get into bitcoin mining with its straightforward contracts that last anywhere from 3 to 24 months. Every contract has a steady hash rate of 60 MH/s, perfect for those who want a predictable and simple mining experience.
For those just starting out or looking for a short-term investment, Hashing24’s 3-Month Plan is a great entry point. It’s priced at $22.20 and offers an estimated mining return of $22.21, essentially allowing you to make back your initial investment quickly. It is ideal for testing the waters of cloud mining without committing to a long-term plan.
Investors aiming for substantial long-term gains will find the 24-Month Plan an excellent option. Priced at $111.60, it offers a projected return of 159%, appealing to those prepared to commit to a longer investment period for significant earnings.
Conclusion
Picking the right cloud mining platform is super important if you want to make money with Bitcoin without doing much work. Platforms like BitFuFu, ZT Mining, and Hashing24 have different plans that last for various times and cost different amounts of money. This means you can find one that fits what you’re comfortable with, whether you’re just getting started with cryptocurrency or you want to make a lot of money. By choosing the best plan for you, you can make your money work for you and watch as it grows over time.
Media Contact
Nancy.Delia, ZT CLOUD SERVICES LIMITED, 44 7301463290, support@ztmining.com, https://ztmining.vip
View original content to download multimedia:https://www.prweb.com/releases/passive-bitcoin-income-the-best-cloud-mining-platforms-for-reliable-earnings-302338359.html
SOURCE ZT Mining
Technology
CATL Launches the Bedrock Chassis That Withstands 120 km/h Impact Without Catching Fire or Exploding
Published
2 hours agoon
December 24, 2024By
NINGDE, China, Dec. 24, 2024 /CNW/ — On December 24th, CATL officially launched the CATL Bedrock Chassis, the world’s first ultra-safe skateboard chassis. With its outstanding performance of withstanding 120 km/h frontal impact without catching fire or exploding, CATL’s Bedrock Chassis sets a new standard for intelligent chassis safety, providing comprehensive protection across all scenarios and speed ranges.
Lead the industry with the most stringent safety tests
With the battery-centered design, CATL’s Bedrock Chassis utilizes Cell-to-Chassis integration technology, which directly integrates the battery cells into the chassis, allowing for a shared structural design between them. And based on the decoupling of the chassis from the upper body, the Bedrock Chassis is capable of absorbing 85% of the vehicle’s collision energy (compared to around 60% absorbed by traditional chassis).
Through various technological breakthroughs, the Bedrock Chassis successfully passed the world’s first “highest speed + strongest impact” dual extreme safety test. This achievement enables the chassis to pass the 120 km/h frontal central pole impact test without catching fire, exploding or thermal runway, redefining the benchmark for safety in the industry.
Currently, the speed for frontal impact safety test in the commonly used C-NCAP (China New Car Assessment Program) is 56km/h, which, when experiencing a frontal impact at this speed, generates collision energy equivalent to falling from 12-meter-high building. In comparison, a frontal impact at 120km/h is equivalent to falling from a 56-meter-high building, generating a collision energy 4.6 times that of collision at 56km/h.
In more stringent frontal pole crash tests, which simulate crashes with non-standard objects such as power poles, large trees, or animals, the impact area is only 1/6 of that in a full-width frontal impact, exponentially increasing impact pressure. At a speed of 120km/h, the impact pressure on the chassis per unit area in a frontal central pole impact is 21 times that of the 56 km/h full-width frontal impact in C-NCAP testing.
Due to the extremely high crash speed and intensity, there has been no previous instance of any new energy vehicle daring to challenge a 120km/h frontal pole impact test. With this extreme challenge, CATL’s Bedrock Chassis has blazed a fresh trail for the industry.
Open the era of ultra-safe transportation through three technological breakthroughs
CATL’s Bedrock Chassis has delved deep into the realm of structure and material innovation, leveraging three technological breakthroughs to provide unparalleled protection in all scenarios and speed ranges, ensuring rock-solid safety for the entire vehicle.
The CATL Bedrock Chassis introduces a revolutionary three-dimensional biomimetic tortoise shell structure, where the body and energy unit framework are integrated, deeply coupled to provide the energy unit with indestructible protection. And its aircraft carrier-grade arresting structure disperses impact forces across multiple pathways during a crash, gradually decelerating the vehicle and significantly reducing the depth and speed at which obstacles intrude the cabin. The utilization of submarine-grade hot-formed steel with a strength of 2000MPa, aerospace-grade aluminum alloy with a strength of 600MPa, and multiple barrier structures further enhance the chassis’ rigidity, making it virtually impervious.
Moreover, the CATL Bedrock Chassis incorporates an ultra-safe battery cell design, NP technology, and a high-ductility energy-absorbing insulation film, leading the industry in a groundbreaking manner. In terms of high-voltage disconnection, it achieves instantaneous disconnection of high voltage circuit within 0.01 seconds of impact and completes the discharge of residual high-voltage energy in the vehicle within 0.2 seconds, setting a new industry record.
Notably, the battery cells have undergone highly demanding tests, including high-speed sled impact tests at 60 km/h, 90-degree bending tests, and breakthrough sawing tests, the battery did not catch fire or explode across all three tests. These tests, all industry-firsts by CATL, have elevated the safety standards of battery cells to new heights.
Unlocking the era of customization, and activating a trillion-yuan market
The launch of the Bedrock Chassis not only redefines the standard for intelligent chassis safety but also activates a trillion-yuan market. It greatly accelerates the shift towards modular, personalized, and intelligent automotive design.
Addressing the common pain points of high investment, long development cycles, and accelerated product iteration in the industry, the Bedrock Chassis incorporates three core characteristics: internal integration, decoupling of the chassis from the upper body, and external openness. With a rich array of toolkits and solution packages, it offers a scalable software and hardware architecture and standardized interfaces, enabling flexible configurations for different vehicle models and scenarios. This allows the realization of a “one chassis architecture, multiple vehicle models” concept and significantly improves development efficiency and shortens the R&D cycle. The time required for mass production of a vehicle is reduced from the traditional 36 months or longer to 12 to 18 months.
Furthermore, the Bedrock Chassis breaks the limits of safety and modeling, and expands design flexibility through the design of decoupling of the chassis from the upper body. The fourth-generation Cell-to-Chassis (CTC) technology and inverted battery cell technology enhance the utilization of chassis space while reducing the risk of chassis scraping. Additionally, in terms of intelligence, the chassis supports mechanical decoupling, software decoupling and EE decoupling, enabling L3 to L4 intelligent driving capabilities. It provides high adaptability interfaces and promotes collaborative intelligent applications.
At the launch ceremony, AVATR, the first automaker to use Bedrock Chassis, and CAIT-SH, CATL’s skateboard chassis arm, signed an agreement to deepen cooperation on CATL’s Bedrock Chassis to create a safer, higher-quality travel experience for users.
Safety is a never-ending journey. In the future, CATL will continue to break technological barriers through continuous innovation, and work with partners to build a safe ecosystem for EV batteries and vehicles, safeguarding the safety of users.
View original content to download multimedia:https://www.prnewswire.com/news-releases/catl-launches-the-bedrock-chassis-that-withstands-120-kmh-impact-without-catching-fire-or-exploding-302338927.html
SOURCE Contemporary Amperex Technology Co., Limited (CATL)
TESSAN Teams Up with One Tree Planted to Launch Global Tree Planting Initiative
What’s next for DeFi in 2025?
Passive Bitcoin Income: The Best Cloud Mining Platforms for Reliable Earnings
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Peloton Unveils Holiday 2022 Creative Campaign Highlighting How Motivation Transcends Beyond the Workout
These ’90s fashion trends are making a comeback in 2017
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Coin Market5 days ago
Tornado Cash dev wants charges dropped after court said OFAC ‘overstepped’
-
Coin Market5 days ago
Chainalysis acquires Web3 security firm Hexagate
-
Technology5 days ago
Veralto Announces Increase in Quarterly Dividend
-
Technology3 days ago
Wrap Up the Holidays with Bedsure Exceptional Discounts
-
Coin Market5 days ago
BIS consultative group proposes retail CBDC architecture
-
Coin Market5 days ago
SEC simultaneously approves Hashdex, Franklin’s Bitcoin-Ether ETFs
-
Technology4 days ago
Playtika Teams Up with IGT to Bring World-Class Slots to Social Casino Games
-
Technology3 days ago
ICEYE expands its Earth Observation capabilities with launch of two SAR satellites for mid-inclination orbit on the Bandwagon-2 mission with SpaceX